Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer (Q41669784)
Jump to navigation
Jump to search
scientific article published on 18 December 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer |
scientific article published on 18 December 2014 |
Statements
1 reference
Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer (English)
1 reference
Ursula A Matulonis
1 reference
Elizabeth Pham
1 reference
Michael J Birrer
1 reference
Scott Eliasof
1 reference
Edward G Garmey
1 reference
Douglas Lazarus
1 reference
Christina R Lee
1 reference
Shan Man
1 reference
Christian G Peters
1 reference
Ping Xu
1 reference
Carolyn Krasner
1 reference
Robert S Kerbel
1 reference
18 December 2014
1 reference
1 reference
Identifiers
1 reference